Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Nasdaq

Where LegalZoom.com Stands With Analysts

Within the last quarter, LegalZoom.com (NASDAQ:LZ) has observed the following analyst ratings:

Benzinga

Where Proterra Stands With Analysts

Within the last quarter, Proterra (NASDAQ:PTRA) has observed the following analyst ratings:

Benzinga

Check Out What Whales Are Doing With Micron Technology

Someone with a lot of money to spend has taken a bearish stance on Micron Technology (NASDAQ:MU). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Expert Ratings for CyberArk Software

Within the last quarter, CyberArk Software (NASDAQ:CYBR) has observed the following analyst ratings:

Benzinga

Where ChromaDex Stands With Analysts

Within the last quarter, ChromaDex (NASDAQ:CDXC) has observed the following analyst ratings:

Benzinga

Check Out What Whales Are Doing With UPST

Someone with a lot of money to spend has taken a bearish stance on Upstart Hldgs (NASDAQ:UPST). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Twitter CEO Gives Update On Musk M&A, Company's Future: Here's What He Said

Following the news of Tesla (NASDAQ: TSLA) CEO Elon Musk putting his acquisition of Twitter (NYSE: TWTR)

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Markets Finish Sharply Higher Amid Ongoing Macro Concerns

U.S. indices traded sharply higher Friday following recent weakness. Markets were highly volatile this week, selling off following the April CPI report, which showed worse-than-expected inflation.

Benzinga

Could Peloton's New Rower Provide A Rally For Beaten-Down Stock?

Connected fitness company Peloton Interactive (NASDAQ: PTON) unveiled a new product Thursday. Here’s the latest and what it could mean.

Benzinga

Why These 3 CyberArk Analysts Cut Price Targets Despite Q1 Beat-And-Raise

Although Cyberark Software Ltd (NASDAQ: CYBR) reported disappointing first-quarter revenue of $127.6 million, its earnings were better than Street ex

Benzinga

5 Analysts Have This to Say About NeuroPace

Over the past 3 months, 5 analysts have published their opinion on NeuroPace (NASDAQ:NPCE) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session

Benzinga

12 Consumer Discretionary Stocks Moving In Friday's Intraday Session

Benzinga

Expert Ratings for Arcellx

Analysts have provided the following ratings for Arcellx (NASDAQ:ACLX) within the last quarter:

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

10 Information Technology Stocks Moving In Friday's Intraday Session

Benzinga

Analyst Ratings for Graphite Bio

Over the past 3 months, 5 analysts have published their opinion on Graphite Bio (NASDAQ:GRPH) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

Mid-Afternoon Market Update: Nasdaq Jumps 400 Points; Duolingo Shares Spike Higher

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite adding 400 points on Friday.

Benzinga

Rivian Automotive Whale Trades For May 13

Someone with a lot of money to spend has taken a bearish stance on Rivian Automotive (NASDAQ:RIVN). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Looking At Starbucks's Recent Whale Trades

Someone with a lot of money to spend has taken a bearish stance on Starbucks (NASDAQ:SBUX). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Ahead Of Upcoming Data On Three Programs, Analysts Remain On Sidelines For Wave Life Sciences

RBC Capital writes that Wave Life Sciences Ltd's (NASDAQ: WVE) Q1 earnings are largely incremental.

Benzinga

Legacy Housing Appoints Ronald Arrington As Finance Head

Legacy Housing Corp (NASDAQ:LEGH) has appointed Ronald Arrington as Chief Financial Officer (CFO). He will replace Jeff Burt, who served as Interim CFO of Legacy, and will remain as the Chief Accounting Officer. Related: Legacy Housing CFO Thomas Kerkaert Resigns Arrington has served as CFO and in other executive positions for construction, retail, and…

Benzinga

Why Real Good Food Shares Are Gaining Today

Real Good Food Company Inc (NASDAQ:RGF) reported first-quarter FY22 sales growth of 124% year-on-year to $37.58 million, beating the consensus of $32.47 million. The revenue increase was driven by strong growth in sales volumes of core products. The gross profit increased 5.8% Y/Y to $4.2 million, and the gross margin contracted 1,260 basis…

Benzinga

Analysts Share Their Views On Affirm Post Q3 Beat

Analysts offered a mixed opinion on Affirm Holdings, Inc (NASDAQ: AFRM)

Benzinga

Here's Why This Analyst Remained Bullish On Microsoft

Tigress Financial Partners analyst Ivan Feinseth reiterated its Buy rating on Microsoft Corp (NASDAQ:MSFT) and maintained the price target of $411 as growth in Cloud continues to drive strong business performance. The recent pullback in price is a significant buying opportunity. Accelerating enterprise digitalization driving increasing IT spending will continue to drive accelerating Business Performance…

Benzinga

InMed Pharmaceuticals Reports Net Sales Of $575K For 6 Months Since BayMedica Acquisition

InMed Pharmaceuticals Inc. (NASDAQ:INM), a leader in research, development, manufacturing and commercialization of rare cannabinoids, released unaudited financial results for the third quarter of the fiscal year 2022 which ended March 31, 2022.

1 … 534 535 536 537

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.